Literature DB >> 30366594

Adult Hepatocytes Are Hedgehog-Responsive Cells in the Setting of Liver Injury: Evidence for Smoothened-Mediated Activation of NF-κB/Epidermal Growth Factor Receptor/Akt in Hepatocytes that Counteract Fas-Induced Apoptosis.

Ying Wang1, Weina Chen2, Chang Han2, Jinqiang Zhang2, Kyoungsub Song2, Hyunjoo Kwon2, Srikanta Dash2, Lu Yao2, Tong Wu3.   

Abstract

Although hedgehog (Hh) signaling pathway is inactive in adult healthy liver, it becomes activated during acute and chronic liver injury and, thus, modulates the reparative process and disease progression. We developed a novel mouse model with liver-specific knockout of Smoothened (Smo LKO), and animals were subjected to Fas-induced liver injury in vivo. Results showed that Smo deletion in hepatocytes enhances Fas-induced liver injury. Activation of Hh signaling in hepatocytes in the setting of Fas-induced injury was indicated by the fact that Jo2 treatment enhanced hepatic expression of Ptch1, Smo, and its downstream target Gli1 in control but not Smo LKO mice. Primary hepatocytes from control mice showed increased Hh signaling activation in response to Jo2 treatment in vitro. On the other hand, the Smo KO hepatocytes were devoid of Hh activation and were more susceptible to Jo2-induced apoptosis. The levels of NF-κB and related signaling molecules, including epidermal growth factor receptor and Akt, were lower in Smo KO livers/hepatocytes than in control livers/hepatocytes. Accordingly, hydrodynamic gene delivery of active NK-κB prevented Jo2-induced liver injury in the Smo LKO mice. Our findings provide important evidence that adult hepatocytes become responsive to Hh signaling through up-regulation of Smo in the setting of Fas-induced liver injury and that such alteration leads to activation of NF-κB/epidermal growth factor receptor/Akt, which counteracts Fas-induced hepatocyte apoptosis.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30366594      PMCID: PMC6207910          DOI: 10.1016/j.ajpath.2018.07.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

Review 1.  Hedgehog signaling in the liver.

Authors:  Alessia Omenetti; Steve Choi; Gregory Michelotti; Anna Mae Diehl
Journal:  J Hepatol       Date:  2010-10-14       Impact factor: 25.083

2.  Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease.

Authors:  J Taïeb; P Mathurin; T Poynard; M A Gougerot-Pocidalo; S Chollet-Martin
Journal:  Lancet       Date:  1998-06-27       Impact factor: 79.321

3.  Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease.

Authors:  Cynthia D Guy; Ayako Suzuki; Marzena Zdanowicz; Manal F Abdelmalek; James Burchette; Aynur Unalp; Anna Mae Diehl
Journal:  Hepatology       Date:  2012-04-18       Impact factor: 17.425

4.  Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.

Authors:  Steve S Choi; Wing-Kin Syn; Gamze F Karaca; Alessia Omenetti; Cynthia A Moylan; Rafal P Witek; Kolade M Agboola; Youngmi Jung; Gregory A Michelotti; Anna Mae Diehl
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

5.  Increased production of sonic hedgehog by ballooned hepatocytes.

Authors:  Fatima Rangwala; Cynthia D Guy; Jiuyi Lu; Ayako Suzuki; James L Burchette; Manal F Abdelmalek; Wei Chen; Anna Mae Diehl
Journal:  J Pathol       Date:  2011-05-05       Impact factor: 7.996

6.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair.

Authors:  Chang-Goo Huh; Valentina M Factor; Aránzazu Sánchez; Koichi Uchida; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

Review 7.  The Hedgehog signal transduction network.

Authors:  David J Robbins; Dennis Liang Fei; Natalia A Riobo
Journal:  Sci Signal       Date:  2012-10-16       Impact factor: 8.192

8.  Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis.

Authors:  Steve S Choi; Alessia Omenetti; Rafal P Witek; Cynthia A Moylan; Wing-Kin Syn; Youngmi Jung; Liu Yang; Debra L Sudan; Jason K Sicklick; Gregory A Michelotti; Marcos Rojkind; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-08       Impact factor: 4.052

9.  Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Steve S Choi; Evaggelia Liaskou; Gamze F Karaca; Kolade M Agboola; Ye Htun Oo; Zhiyong Mi; Thiago A Pereira; Marzena Zdanowicz; Padmini Malladi; Yuping Chen; Cynthia Moylan; Youngmi Jung; Syamal D Bhattacharya; Vanessa Teaberry; Alessia Omenetti; Manal F Abdelmalek; Cynthia D Guy; David H Adams; Paul C Kuo; Gregory A Michelotti; Peter F Whitington; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

10.  CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly.

Authors:  Russell G Jones; Alisha R Elford; Michael J Parsons; Linda Wu; Connie M Krawczyk; Wen-Chen Yeh; Razqallah Hakem; Robert Rottapel; James R Woodgett; Pamela S Ohashi
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  2 in total

Review 1.  "Hedgehog pathway": a potential target of itraconazole in the treatment of cancer.

Authors:  Xin Wei; Wu Liu; Jia Qi Wang; Zeyao Tang
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-20       Impact factor: 4.553

Review 2.  Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma.

Authors:  Kuo-Shyang Jeng; Chi-Juei Jeng; Wen-Juei Jeng; I-Shyan Sheen; Shih-Yun Li; Chuen-Miin Leu; Yeou-Guang Tsay; Chiung-Fang Chang
Journal:  Oncol Lett       Date:  2019-09-09       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.